Navigation Links
Bruin Biometrics Formalizes Management Structure with Appointment of Jeff Greiner and Eve Kurtin to Board of Directors, Plus Additional Executive Leadership
Date:12/2/2013

LOS ANGELES, Dec. 2, 2013 /PRNewswire/ -- Bruin Biometrics, LLC ("BBI") a medical device company developing innovative, point of care diagnostic devices, announced today the appointment of two new board members and the expansion of the executive team.

(Logo; http://photos.prnewswire.com/prnh/20131018/LA00429LOGO)

Jeff Greiner joins the BBI board after serving 18 years leading Advanced Bionics, a medical device company that developed spinal cord stimulators and cochlear implants. The company was sold for over $3 billion dollars and is now owned by Boston Scientific (neuromodulation division) and Sonova (cochlear implant division).

Eve Kurtin joins the BBI Board with over 20 years of experience as an operating executive and investor in healthcare. Eve is Managing Director of Pacific Venture Group and Senior Advisor of VantagePoint Capital Partners. She is also a founding member of the RAND Health Board of Advisors, an assembly of national leaders working to improve the U.S. healthcare system.

Rob Pecsar joins BBI as Vice President of Research & Development. Rob has previously launched 18 medical products at a variety of companies including Alaris Medical Systems, Cardinal Health, CareFusion, Gen-Probe, IMED, and Infrasonics, Inc.

Armin Beck joins BBI as Vice President of Quality, Regulatory, Manufacturing, and Operations. He has over 30 years experience leading international commercial product launches and most recently directed Quality Assurance, Regulatory, and Clinical Affairs at Cardica, Inc.

Mark Bruns joins BBI as Vice President of Commercial Operations and Sales. Mark has over 30 years of experience, most recently as a transformational leader in sales and marketing at Alaris Medical Systems, Cardinal Health, and CareFusion.

Sally Grigoriev joins BBI as Senior Advisor, Operations. Sally was previously Senior Vice President of Manufacturing and Operations at CareFusion and Cardinal Health.  She has over 25 years of R&D, Quality, Regulatory, Manufacturing, and Operations experience within the medical device industry.

BBI Chief Executive Martin Burns commented, "We have been extremely diligent about finding the right people who understand BBI's strategy and also have the talent to execute upon BBI's business goals. Our combined team has launched over 30 medical products and technologies, and we are united in our mission to solve pressing clinical challenges."

To learn more about BBI please visit www.bruinbiometrics.com.


'/>"/>
SOURCE Bruin Biometrics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bruin Biometrics, LLC führt klinische Studie zum Nachweis von Druckgeschwüren mit dem SEM Scanner durch
2. Bruin Biometrics, LLC Conducts Clinical Trials to Detect Pressure Ulcers with the SEM Scanner
3. Bruin Biometrics, LLC Announces New Board Members
4. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
5. Biometrics Limits Abuse while Improving Convenience
6. Virtify Announces Second Webinar on Regulatory Information Management Strategies for Small and Mid-Sized Pharmas
7. Lorus Therapeutics Completes New Executive Management Team
8. The Modern Algorithm For Management Of Massive And Submassive Pulmonary Embolism
9. The Huntzinger Management Group, Inc. (HMG) Reporting Significant Growth and Business Expansion in 2013
10. Array BioPharma Announces Management Team Change
11. Implantable Medical Device Group formed to Reduce Risk and Simplify Management of Active Implant Projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2, 2016  UCB is pleased to announce that 12 scientific ... 70 th American Epilepsy Society (AES) Annual Meeting, which ... , USA. 1-12 Data being ... of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... the current state of the union of epilepsy care and ...
(Date:12/2/2016)... , December 2, 2016 The iShares ... past losses following Trump,s victory early in November. Less ... fund managers are now predicting an uptick in M&A ... equities to see how they have fared at the ... ), Amicus Therapeutics Inc. (NASDAQ: FOLD ), ...
(Date:11/30/2016)... -- Research and Markets has announced the addition of ... report to their offering. ... Detachable coil embolization is a minimally ... detachable coil embolization treatment of cerebral aneurysms is less invasive and requires ... in the wall of an artery in the brain. This area bulges ...
Breaking Medicine Technology:
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers ... as a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes ... an honor to be designated a Cigna Infertility Center of Excellence," said Fertility ...
(Date:11/30/2016)... , ... November 30, 2016 , ... "I hate when ... arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that ... develop this handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and ...
(Date:11/30/2016)... FL (PRWEB) , ... November 30, 2016 , ... ... disorder and mental health treatment has announced the opening of a new eating ... partial hospitalization and intensive outpatient treatment for adults and adolescents, both males and ...
(Date:11/30/2016)... ... November 30, 2016 , ... In recent policy debates, increasing ... public policymakers and system stakeholders in many states. To help them understand this ... Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , “If you are a ...
(Date:11/30/2016)... ... 30, 2016 , ... The Clinical Data Interchange Standards Consortium ... Guidance goes into effect next month. Sponsors whose studies start after December 17, ... Catalog. The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):